106 related articles for article (PubMed ID: 4882472)
21. Preliminary clinical trial of 1-(2-chlorethyl)-3-(4-methylcyclohexyl)-1 nitrosourea (NSC-95411) (MeCCNU) in human neoplasms.
Gailani S; Kutcher J
J Med; 1973; 4(4):209-18. PubMed ID: 4520348
[No Abstract] [Full Text] [Related]
22. Prevalence of a common point mutation in the dihydropyrimidine dehydrogenase (DPD) gene within the 5'-splice donor site of intron 14 in patients with severe 5-fluorouracil (5-FU)- related toxicity compared with controls.
Raida M; Schwabe W; Häusler P; Van Kuilenburg AB; Van Gennip AH; Behnke D; Höffken K
Clin Cancer Res; 2001 Sep; 7(9):2832-9. PubMed ID: 11555601
[TBL] [Abstract][Full Text] [Related]
23. Biochemical modulation in the treatment of advanced cancer: a study of combined leucovorin, fluorouracil, and iododeoxyuridine.
Marshall JL; Richmond E; DeLap RJ
Clin Cancer Res; 1996 Sep; 2(9):1475-80. PubMed ID: 9816323
[TBL] [Abstract][Full Text] [Related]
24. [Comparative evaluation of the efficacy of fluorofur (Ftorafur) and 5-fluorouracil (5-ftouracil) in the treatment of breast cancer].
Karev N; Blokhina N; Voznyi E; Perscin M
Minerva Med; 1974 Jul; 65(52):2811-4. PubMed ID: 4846402
[No Abstract] [Full Text] [Related]
25. Phase I study of a combination of azotomycin (NSC-56654) and 5-fluorouracil (NSC-19893) in malignant disease.
Weiss AJ; Mastrangelo MJ
Cancer Chemother Rep; 1970 Apr; 54(2):109-11. PubMed ID: 4946000
[No Abstract] [Full Text] [Related]
26. Evaluation of the combination of hexamethylmelamine (NSC-13875) and methotrexate (NSC-740) in carcinoma of the lung.
Weiss AJ; Wilson WL
Cancer Chemother Rep; 1971 Jun; 55(3):299-302. PubMed ID: 5115850
[No Abstract] [Full Text] [Related]
27. [1st experiences in the treatment of ovarian tumors with Peptichemio].
Natale N; Mangioni C; Remotti G
Minerva Med; 1974 May; 65(33):1805-10. PubMed ID: 4367233
[No Abstract] [Full Text] [Related]
28. [A late phase II trial of l-leucovorin and 5-fluorouracil in advanced colorectal cancer. l-Leucovorin and 5-FU Study Group (Japan Western Group)].
Konishi K; Yabushita K; Taguchi T; Ota J; Takashima S; Abe T; Kikkawa N; Yasutomi M; Sowa M; Maehara Y
Gan To Kagaku Ryoho; 1995 Jun; 22(7):925-32. PubMed ID: 7793998
[TBL] [Abstract][Full Text] [Related]
29. The effect of 5-fluorouracil on small bowel mucosa.
White RS; Fuqua WB; Barrett O
J Surg Oncol; 1971; 3(5):501-6. PubMed ID: 5114102
[No Abstract] [Full Text] [Related]
30. Oxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancer.
Chau I; Webb A; Cunningham D; Hill M; Waters JS; Norman A; Massey A
Br J Cancer; 2001 Nov; 85(9):1258-64. PubMed ID: 11720458
[TBL] [Abstract][Full Text] [Related]
31. [Adriamycin in chemotherapy of solid tumors].
Lovisetto P; Pochettino G; Biarese V
Minerva Med; 1975 May; 66(35):1653-63. PubMed ID: 1128811
[TBL] [Abstract][Full Text] [Related]
32. 5-fluorouracil modulated by leucovorin, methotrexate and mitomycin: highly effective, low-cost chemotherapy for advanced colorectal cancer.
Sobrero A; Guglielmi A; Cirillo M; Recaldin E; Frassineti GL; Aschele C; Ravaioli A; Testore P; Caroti C; Gallo L; Pessi MA; Cortesi E; Turci D; Grossi F; Labianca R
Br J Cancer; 2001 Apr; 84(8):1023-8. PubMed ID: 11308248
[TBL] [Abstract][Full Text] [Related]
33. Basal-cell carcinoma. A case unmasked by systemic fluorouracil therapy.
Scialla SJ; Miskoff RA
JAMA; 1976 May; 235(22):2416-7. PubMed ID: 946650
[No Abstract] [Full Text] [Related]
34. Initial clinical (phase I) trial of TLC D-99 (doxorubicin encapsulated in liposomes).
Cowens JW; Creaven PJ; Greco WR; Brenner DE; Tung Y; Ostro M; Pilkiewicz F; Ginsberg R; Petrelli N
Cancer Res; 1993 Jun; 53(12):2796-802. PubMed ID: 8504422
[TBL] [Abstract][Full Text] [Related]
35. The variability of individual tolerance to methotrexate in cancer patients.
Hansen HH; Selawry OS; Holland JF; McCall CB
Br J Cancer; 1971 Jun; 25(2):298-305. PubMed ID: 4256007
[TBL] [Abstract][Full Text] [Related]
36. [Changes in the hematopoietic system during treatment with 5-fluorouracil].
Voznyĭ EK
Vopr Onkol; 1970 Apr; 16(4):64-7. PubMed ID: 5454548
[No Abstract] [Full Text] [Related]
37. Phase II study of mitomycin C, cisplatin and 5-fluorouracil for advanced and recurrent gastric cancer.
Kikuyama S; Inada T; Oyama R; Ogata Y
Anticancer Res; 2002; 22(6B):3633-6. PubMed ID: 12552968
[TBL] [Abstract][Full Text] [Related]
38. Treatment of metastatic Ewing's sarcoma with actinomycin D (NSC-3053).
Senyszyn JJ; Johnson RE; Curran RE
Cancer Chemother Rep; 1970 Apr; 54(2):103-7. PubMed ID: 4945999
[No Abstract] [Full Text] [Related]
39. Phase I clinical trial: pharmacokinetics of a novel anthracycline, DA-125 and metabolites. Single dose study.
Roh JK; Rha SY; Lee CI; Lee KH; Lee JJ; Shim HJ; Lee SD; Kim WB; Yang J; Kim SH; Lee MG
Int J Clin Pharmacol Ther; 1998 Jun; 36(6):312-9. PubMed ID: 9660038
[TBL] [Abstract][Full Text] [Related]
40. Bleomycin (NSC-125066): phase I clinical study.
Sonntag RW
Cancer Chemother Rep; 1972 Apr; 56(2):197-205. PubMed ID: 4114485
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
